UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in SRPT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,026,538
+$290,407 QoQ
Shares Held
276,955
+3.9% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 37.602859670343555.ToString("F0")%
Shared 0.ToString("F0")%
None 62.397140329656445.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. SRPT ranks #59 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,026,538 | 276,955 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,736,131 | 266,549 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,498,789 | 233,461 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,774,451 | 396,167 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,570,479 | 463,342 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $36,392,005 | 299,301 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,495,868 | 268,203 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,633,998 | 301,481 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,846,551 | 161,027 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,526,384 | 161,012 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,538,479 | 161,182 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,944,020 | 156,689 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,596,441 | 156,689 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,720,771 | 121,321 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,272,204 | 120,067 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,382,480 | 138,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,745,012 | 137,545 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,835,372 | 164,746 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,441,372 | 102,091 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,685,341 | 111,723 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,281,775 | 205,042 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $69,313,558 | 406,555 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $55,593,284 | 395,879 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $63,420,719 | 395,539 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $44,592,122 | 455,859 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||